Vivani Medical Announces $8.25M Private Placement Equity Financing
Provided By GlobeNewswire
Last update: Mar 27, 2025
Financing strengthens balance sheet, extending expected runway into the second quarter of 2026
Enables accelerated development of NPM-139, Company’s once or twice-yearly GLP-1 (semaglutide) implant under development for chronic weight management
Read more at globenewswire.comNASDAQ:VANI (6/13/2025, 12:21:04 PM)
1.18
-0.01 (-0.84%)
Find more stocks in the Stock Screener
